SCHEMBL2599707

SCHEMBL2599707

OCc1cc(C2CC2)cc(C2CC2)c1OC(F)(F)F

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.30
FFAR4 Q5NUL3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16961115 0.78 ALOX5AP (0.36) HTR2C
SCHEMBL671184 0.77 FFAR4 (0.34) HTR2CFFAR4
SCHEMBL16954185 0.75 MGLL (0.40) FFAR4
SCHEMBL2599724 0.72 ESR2 (0.33)
SCHEMBL16960072 0.72 FFAR4 (0.42) HTR2CFFAR4
SCHEMBL16957587 0.70 FFAR4 (0.42) HTR2CFFAR4
SCHEMBL14689866 0.68 FFAR4 (0.32) HTR2CFFAR4
SCHEMBL16954480 0.67 ESR2 (0.40)
SCHEMBL3908320 0.67 EPHX1 (0.37) HTR2C
SCHEMBL16959404 0.66 EPHX1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2571356-A1 SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS Merck Sharp & Dohme Corp. (US) 2013-03-27 EP disclosed
WO-2011146324-A1 SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2011-11-24 WO disclosed